0001209191-20-057052.txt : 20201104
0001209191-20-057052.hdr.sgml : 20201104
20201104201635
ACCESSION NUMBER: 0001209191-20-057052
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200711
FILED AS OF DATE: 20201104
DATE AS OF CHANGE: 20201104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Shah Jatin
CENTRAL INDEX KEY: 0001782186
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 201288286
MAIL ADDRESS:
STREET 1: C/O KARYOPHARM THERAPEUTICS, INC.
STREET 2: 85 WELLS AVENUE
CITY: NEWTON
STATE: MA
ZIP: 02459
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-07-11
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001782186
Shah Jatin
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVE.
NEWTON
MA
02459
0
1
0
0
EVP, Chief Medical Officer
Common Stock
2020-07-11
4
M
0
2413
A
43172
D
Common Stock
2020-07-15
4
S
0
589
19.46
D
43229
D
Restricted Stock Units
2020-07-11
4
M
0
2413
0.00
D
Common Stock
2413
7237
D
Restricted stock units convert into Karyopharm Therapeutics Inc. common stock on a one-for-one basis.
This transaction was a broker-assisted sale of shares to satisfy the payment of withholding tax liability incurred upon the vesting of restricted stock units and does not represent a discretionary trade by the reporting person.
Includes 646 shares acquired by the reporting person under the Karyopharm Therapeutics Inc. 2013 Employee Stock Purchase Plan on October 31, 2020.
On July 11, 2019, the reporting person was granted 9,650 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. 25% of the restricted stock units vested on July 11, 2020. Vested shares will be delivered to the reporting person as soon as practicable following the vesting date, but in any event within 30 days of such date.
/s/Christopher B. Primiano, Attorney-in-Fact for Jatin Shah
2020-11-04